These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 20858749

  • 1. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.
    He L, Zeng H, Li F, Feng J, Liu S, Liu J, Yu J, Mao J, Hong T, Chen AF, Wang X, Wang G.
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1061-5. PubMed ID: 20858749
    [Abstract] [Full Text] [Related]

  • 2. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
    Yan TT, Li Q, Zhang XH, Wu WK, Sun J, Li L, Zhang Q, Tan HM.
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
    [Abstract] [Full Text] [Related]

  • 3. [Effect of Tongxinluo superfine on experimental anginal model (contraction of collaterals) in rat with endothelial dysfunction].
    Han YL, Cheng C, Tan HM, Wu WK, Wu YL, Sun HL, Sun J, Chen JL.
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2404-8, 2426. PubMed ID: 18257270
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.
    Eur J Pharmacol; 2005 Mar 21; 511(1):53-64. PubMed ID: 15777779
    [Abstract] [Full Text] [Related]

  • 6. Endothelial cell dysfunction in a model of oxidative stress.
    Jin L, Abou-Mohamed G, Caldwell RB, Caldwell RW.
    Med Sci Monit; 2001 Mar 21; 7(4):585-91. PubMed ID: 11433181
    [Abstract] [Full Text] [Related]

  • 7. Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia.
    Liu J, Xu Y, Zhang H, Gao X, Fan H, Wang G.
    J Hum Hypertens; 2014 Dec 21; 28(12):743-7. PubMed ID: 24670326
    [Abstract] [Full Text] [Related]

  • 8. Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries.
    Ramaswami G, Chai H, Yao Q, Lin PH, Lumsden AB, Chen C.
    J Vasc Surg; 2004 Dec 21; 40(6):1216-22. PubMed ID: 15622377
    [Abstract] [Full Text] [Related]

  • 9. The role of hyperhomocysteinemia in nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation.
    Heil SG, De Vriese AS, Kluijtmans LA, Mortier S, Den Heijer M, Blom HJ.
    Cell Mol Biol (Noisy-le-grand); 2004 Dec 21; 50(8):911-6. PubMed ID: 15704255
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Physcion, a tetra-substituted 9,10-anthraquinone, prevents homocysteine-induced endothelial dysfunction by activating Ca2+- and Akt-eNOS-NO signaling pathways.
    Ji XW, Lyu HJ, Zhou GH, Wu B, Zhu YY, Wu TH, Zhang F, Jin SN, Cho KW, Wen JF.
    Phytomedicine; 2021 Jan 21; 81():153410. PubMed ID: 33285470
    [Abstract] [Full Text] [Related]

  • 12. Acute hyperhomocysteinemia induces microvascular and macrovascular endothelial dysfunction.
    Abahji TN, Nill L, Ide N, Keller C, Hoffmann U, Weiss N.
    Arch Med Res; 2007 May 21; 38(4):411-6. PubMed ID: 17416288
    [Abstract] [Full Text] [Related]

  • 13. Tetrahydrobiopterin attenuates homocysteine induced endothelial dysfunction.
    Dhillon B, Badiwala MV, Maitland A, Rao V, Li SH, Verma S.
    Mol Cell Biochem; 2003 May 21; 247(1-2):223-7. PubMed ID: 12841652
    [Abstract] [Full Text] [Related]

  • 14. Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation.
    Cheng Z, Jiang X, Pansuria M, Fang P, Mai J, Mallilankaraman K, Gandhirajan RK, Eguchi S, Scalia R, Madesh M, Yang X, Wang H.
    Diabetes; 2015 Mar 21; 64(3):947-59. PubMed ID: 25352635
    [Abstract] [Full Text] [Related]

  • 15. Acute hyperhomocysteinemia impairs endothelium function in subjects with type 2 diabetes mellitus.
    Doupis J, Eleftheriadou I, Kokkinos A, Perrea D, Pavlatos S, Gonis A, Katsilambros N, Tentolouris N.
    Exp Clin Endocrinol Diabetes; 2010 Jul 21; 118(7):453-8. PubMed ID: 20200816
    [Abstract] [Full Text] [Related]

  • 16. Elevated level of plasma homocysteine in patients with slow coronary flow.
    Riza Erbay A, Turhan H, Yasar AS, Ayaz S, Sahin O, Senen K, Sasmaz H, Yetkin E.
    Int J Cardiol; 2005 Jul 20; 102(3):419-23. PubMed ID: 16004886
    [Abstract] [Full Text] [Related]

  • 17. Adult rats are more sensitive to the vascular effects induced by hyperhomocysteinemia than young rats.
    de Andrade CR, de Campos GA, Tirapelli CR, Laurindo FR, Haddad R, Eberlin MN, de Oliveira AM.
    Vascul Pharmacol; 2010 Jul 20; 53(3-4):99-106. PubMed ID: 20450986
    [Abstract] [Full Text] [Related]

  • 18. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes.
    Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G, Bauersachs J.
    Diabetes; 2007 Mar 20; 56(3):666-74. PubMed ID: 17327434
    [Abstract] [Full Text] [Related]

  • 19. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.
    Voisine P, Li J, Bianchi C, Khan TA, Ruel M, Xu SH, Feng J, Rosinberg A, Malik T, Nakai Y, Sellke FW.
    Circulation; 2005 Aug 30; 112(9 Suppl):I202-7. PubMed ID: 16159817
    [Abstract] [Full Text] [Related]

  • 20. Homocysteine and endothelial function in human studies.
    Moat SJ, McDowell IF.
    Semin Vasc Med; 2005 May 30; 5(2):172-82. PubMed ID: 16047269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.